Informed consent in phase I clinical trials: Implications for trends in design. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a full text ...
Health care is undergoing an important and well-needed shift from a one-size-fits-all approach to more personalized, precise, patient-focused care. A similar approach needs to be implemented at scale ...
Faculty in the Statistical Learning and Data Science Hub advance statistical and machine learning methods tailored to the unique challenges of biomedical and epidemiologic data, including ...
User-centred design and adaptive interfaces represent a dynamic evolution in the field of human-computer interaction, merging the principles of accessibility, inclusivity and usability with ...
LOS ANGELES--(BUSINESS WIRE)--Global Coalition for Adaptive Research, the U.S. Sponsor of REMAP-COVID, announced that Eisai has ended the evaluation of eritoran in the REMAP-COVID study. Eritoran, an ...
Establishment Labs Holdings ((ESTA)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...
Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension
BOSTON and ATLANTA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback